Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Synold, T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 9 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Margolin, K; Synold, T; Longmate, J; Doroshow, JH
      Methodologic guidelines for the design of high-dose chemotherapy regimens

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    2. Morgan, RJ; Synold, T; Carr, BI; Doroshow, JH; Womack, EP; Shibata, S; Somlo, G; Raschko, J; Leong, L; McNamara, M; Chow, W; Tetef, M; Margolin, K; Akman, S; Longmate, J
      Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    3. Somlo, G; Doroshow, JH; Synold, T; Longmate, J; Reardon, D; Chow, W; Forman, SJ; Leong, LA; Margolin, KA; Morgan, RJ; Raschko, JW; Shibata, SI; Tetef, ML; Yen, Y; Kogut, N; Schriber, J; Alvarnas, J
      High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome

      BRITISH JOURNAL OF CANCER
    4. Roberts, JD; Poplin, EA; Tombes, MB; Kyle, B; Spicer, DV; Grant, S; Synold, T; Moran, R
      Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    5. GANDARA DR; LARA P; CADMAN T; LAU D; UHRICH M; TURRELL C; MORGAN R; DIMERY I; EDELMAN M; PEREZ EA; SYNOLD T; DOROSHOW J; MUGGIA F; DEGREGORIO M
      HIGH-DOSE TOREMIFENE AS A CISPLATIN MODULATOR - TARGETED PLASMA-LEVELS ARE ACHIEVABLE CLINICALLY

      Journal of investigative medicine
    6. LARA PN; GANDARA DR; WURZ GT; LAU D; UHRICH M; TURRELL C; RASCHKO J; EDELMAN MJ; SYNOLD T; DOROSHOW J; MUGGIA F; PEREZ EA; DEGREGORIO M
      HIGH-DOSE TOREMIFENE AS A CISPLATIN MODULATOR IN METASTATIC NONSMALL CELL LUNG-CANCER - TARGETED PLASMA-LEVELS ARE ACHIEVABLE CLINICALLY

      Cancer chemotherapy and pharmacology
    7. PUI CH; BOYETT JM; HUGHES WT; RIVERA GK; HANCOCK ML; SANDLUND JT; SYNOLD T; RELLING MV; RIBEIRO RC; CRIST WM; EVANS WE
      HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER INDUCTION CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA

      The New England journal of medicine
    8. MIASKOWSKI C; NICHOLS R; BRODY R; SYNOLD T
      ASSESSMENT OF PATIENT SATISFACTION UTILIZING THE AMERICAN-PAIN-SOCIETY QUALITY ASSURANCE STANDARDS ON ACUTE AND CANCER-RELATED PAIN

      Journal of pain and symptom management
    9. CROM WR; DEGRAAF SSN; SYNOLD T; UGES DRA; BLOEMHOF H; RIVERA G; CHRISTENSEN ML; MAHMOUD H; EVANS WE
      PHARMACOKINETICS OF VINCRISTINE IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA

      The Journal of pediatrics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 11:15:46